For example, FLT3, a critical receptor tyrosine kinase mutated in up to 35% of acute myeloid leukemia (AML) cases was found to be one of the three highest impact genes in all three AML datasets. This evidence concerns the gene NTRK1 and acute myeloid leukemia.